Literature DB >> 11191262

An overview of group sequential methods in longitudinal clinical trials.

B Spiessens1, E Lesaffre, G Verbeke, K Kim, D L DeMets.   

Abstract

During the last decade, several papers have been published on group sequential methods in general and on sequential longitudinal clinical trials in particular. This paper gives an overview of the proposed methods, emphasizing longitudinal clinical trials. Furthermore, it tries to answer some practical questions that may arise during the conduct of interim analyses in longitudinal trials. Simulations have been carried out to obtain insight in these practical considerations.

Mesh:

Year:  2000        PMID: 11191262     DOI: 10.1177/096228020000900506

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  3 in total

1.  Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods.

Authors:  Steven A Dezell; Yong-Oon Ahn; Jan Spanholtz; Hongbo Wang; Matthew Weeres; Scott Jackson; Sarah Cooley; Harry Dolstra; Jeffrey S Miller; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-07       Impact factor: 5.742

2.  A comparison of methods for treatment selection in seamless phase II/III clinical trials incorporating information on short-term endpoints.

Authors:  Cornelia Ursula Kunz; Tim Friede; Nicholas Parsons; Susan Todd; Nigel Stallard
Journal:  J Biopharm Stat       Date:  2015       Impact factor: 1.051

3.  Changing the Paradigm for the Treatment and Development of New Therapies for FSGS.

Authors:  Cathie Spino; Jordan S Jahnke; David T Selewski; Susan Massengill; Jonathan Troost; Debbie S Gipson
Journal:  Front Pediatr       Date:  2016-03-23       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.